Leadless pacemakers soon available for all patients
Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium… read more.
Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium… read more.
Adults at high cardiovascular risk and living with overweight or obesity [1] experience a higher number of cardiovascular events (such as heart attack and stroke), are at greater… read more.
Statin therapy appears to reduce the risk of stroke or transient ischemic attack in patients with atrial fibrillation, and longer use gives more protection. The findings were presented… read more.
The study, led by researchers from University of Bristol, is based on data from the world-renowned longitudinal health study, Children of the 90s (officially known as the Avon Longitudinal Study… read more.
A new study showed that hysterectomy alone, hysterectomy with oophorectomy, and tubal ligation were all associated with an increased risk of cardiovascular disease (CVD). The findings and their… read more.
GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older… read more.
New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS. The University of Bristol-led study, published in Arthritis & Rheumatology, analysed… read more.
Strength training practiced with moderate to vigorous intensity two or three times a week is an effective way to mitigate arterial hypertension (high blood pressure), according to a… read more.
The hunger hormone ghrelin appears to increase pumping capacity in patients with heart failure, researchers reported on March 14, 2023 in European Heart Journal. “Heart failure is the… read more.
Dr Rani Khatib is a Consultant Cardiology Pharmacist at Leeds Teaching Hospitals NHS Trust and Associate Professor at the Leeds Institute for Cardiometabolic Medicine (LICaM), University of Leeds. As… read more.
The updated and expanded NICE quality standards should be used in all care settings to audit and improve services for people with chronic heart failure, according to Dr… read more.
Dr Rani Khatib is a consultant pharmacist in cardiology and cardiovascular research and associate professor at the University of Leeds. As a member of the NICE Guideline Development… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.